Trial Profile
A Single-center, Open-label Positron Emission Tomography Study to Evaluate the Time-course of Displacement of [11C]UCB-J by Brivaracetam and Levetiracetam in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary) ; Brivaracetam (Primary) ; Levetiracetam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors UCB
- 29 Mar 2019 Results evaluating human brain penetration and SV2A occupancy of Brivaracetam and levetiracetam published in the Epilepsia
- 27 Oct 2017 Status changed from recruiting to completed.
- 11 May 2017 Status changed from completed to recruiting.